Address
Novo A/S
19 Tuborg Havnevej
2900 Hellerup
Denmark
Website
Recent investment activity
KANDO id: 30981
Relation
Renamed to
Funding rounds
Investment preferences
Investment activity status
Not investing
Selected investments
Displaying 26 - 28 of 28| Company | Profile | Country | Date | Funding | ||
|---|---|---|---|---|---|---|
![[current-page:title] logo](/sites/default/files/styles/icon/public/default_images/_no-logo.png?itok=AH4pbDYM){kind=icon}
|
High Throughput Genomics Inc | Series D | ||||
|
|
Orphazyme ApS | Orphazyme develops innovative new therapies for the treatment of a family of serious genetic disordes called lysosomal storage diseases. | Series A | |||
|
|
Orphazyme ApS | Orphazyme develops innovative new therapies for the treatment of a family of serious genetic disordes called lysosomal storage diseases. | Seed |